A Phase Ib/IIa Single Centre, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Dose Ranging Trial in Adult Participants With Uncomplicated Dengue Fever in Singapore
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 02 May 2017
At a glance
- Drugs Modipafant (Primary) ; Celgosivir
- Indications Dengue
- Focus Therapeutic Use
- 02 May 2017 Last checked against ClinicalTrails.gov record.
- 25 Apr 2017 Planned initiation date changed from 1 Jul 2016 to 1 Jul 2017.
- 06 Oct 2015 Status changed from planning to not yet recruiting, as reported by ClinicalTrials.gov.